G(e)nomes and trolls – DNA sequencing and risk

2017 was intended to be a landmark year for the development of ‘genomic services’ – a term coined by the Department for Health in 2012 when it launched the Genomes project. Whilst this year’s initial deadline has passed and been pushed back to 2018, all signs are still pointing towards DNA sequencing being the next big revolution in healthcare advances, with the intention of sequencing 100,000 genomes from NHS patients.

In the early noughties, scientists were hard at work developing the publication of the first complete genome in an effort to provide a DNA bible by which future medicine would abide. However, in 2017 DNA sequencing is now making itself uncompromisingly known in the daily lives of healthcare practitioners in some of the most important fields of treatment.

Continue reading

Is the healthcare sector suffering from PBSD (Pre-Brexit Stress Disorder)?

Funding the NHS formed a key part of the Leave campaign, with pledges to spend £350m per week on the NHS from the savings made on EU contributions.  Within hours of the referendum result being announced, Nigel Farage admitted that this pledge was “a mistake” and that this additional funding would not in fact be available post-Brexit.

There remains uncertainty at this stage as to the precise long-term effects Brexit will have on the NHS and the healthcare sector as a whole.  Ahead of the referendum, the Economist Intelligence Unit produced a white paper on the likely impact Brexit would have on the healthcare industry and its predictions have so far proved to be particularly accurate.

Continue reading